Inspire Investing, LLC Chimerix Inc Transaction History

Inspire Investing, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$5.23 - $7.18 $423,854 - $581,888	-81,043 Closed	0 $0
Q3 2021 Nov 09, 2021	BUY	$5.94 - $8.75 $481,395 - $709,126	81,043 New	81,043 $502,000
Q2 2020 Aug 12, 2020	SELL	$1.33 - $3.63 $5,769 - $15,746	-4,338 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$1.27 - $2.33 $8,483 - $15,564	-6,680 Reduced 60.63%	4,338 $6,000
Q4 2019 Jan 24, 2020	BUY	$1.3 - $2.72 $14,323 - $29,968	11,018 New	11,018 $22,000
Q1 2018 Apr 13, 2018	SELL	$4.65 - $5.9 $19,543 - $24,797	-4,203 Closed	0 $0
Q4 2017 Feb 15, 2018	BUY	$4.32 - $5.52 $18,156 - $23,200	4,203	4,203 $19,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Inspire Investing, LLC, based on Form 13F filings with the SEC.

Stay updated on Inspire Investing, LLC with notifications on news.